Summit 2022 对比 Updates in NHL Management 的使用情况和统计数据

Dear Colleagues, Summit 2022 is the 9th joint project of EHOG and MD Anderson Cancer Center Leukemia Department that will take place on May, 7-8 in İstanbul. We are extremely happy to be able to organize this meeting in person after two years due to the pandemic. As every year, distinguished MD Anderson Cancer CenterLeukemia Department physicians along with the other distinguished speakers from Europe will present their latest research findings and perspectives on the hematologic diseases at this two-day meeting. The concept of the meeting is based on interactive presentations where the audience will be able to ask online questions to the speakers. Looking forward to welcoming you to beautiful Istanbul. On behalf of the Organizing Committee, Prof. Birol Güvenç, MD
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

In the management of non-Hodgkin lymphoma (NHL), multiple mechanisms of therapy have been developed. These therapies include anti-CD20 antibodies and chimeric antigen receptor T-cell (CAR-T) therapies. With continued developments in NHL management, bispecific antibodies are a promising strategy for use in the relapsed/refractory setting with promising data showing potential for improving outcomes in patient care.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

Summit 2022与Updates in NHL Management排名比较

对比 Summit 2022 与 Updates in NHL Management 在过去 28 天内的排名趋势

排名

没有可用的数据

Summit 2022 对比 Updates in NHL Management 的排名,按国家/地区比较

对比 Summit 2022 与 Updates in NHL Management 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
Summit 2022 VS.
Updates in NHL Management

十二月 15, 2024